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In the adult central nervous system (CNS), chemokines and their receptors are involved
in developmental, physiological and pathological processes. Although most lines of
investigation focus on their ability to induce the migration of cells, recent studies indicate
that chemokines also promote cellular interactions and activate signaling pathways that
maintain CNS homeostatic functions. Many homeostatic chemokines are expressed on the
vasculature of the blood brain barrier (BBB) including CXCL12, CCL19, CCL20, and CCL21.
While endothelial cell expression of these chemokines is known to regulate the entry
of leukocytes into the CNS during immunosurveillance, new data indicate that CXCL12
is also involved in diverse cellular activities including adult neurogenesis and neuronal
survival, having an opposing role to the homeostatic chemokine, CXCL14, which appears
to regulate synaptic inputs to neural precursors. Neuronal expression of CX3CL1, yet
another homeostatic chemokine that promotes neuronal survival and communication with
microglia, is partly regulated by CXCL12. Regulation of CXCL12 is unique in that it may
regulate its own expression levels via binding to its scavenger receptor CXCR7/ACKR3.
In this review, we explore the diverse roles of these and other homeostatic chemokines
expressed within the CNS, including the possible implications of their dysfunction as a
cause of neurologic disease.
Keywords: chemokines, central nervous system, blood brain barrier, homeostasis, vasculature, choroid plexus,
meninges, neurogenesis
INTRODUCTION
Our understanding of the role of chemokine expression in the
adult central nervous system (CNS) has shifted away from view-
ing these molecules primarily as proinflammatory mediators
and more towards their ability to exert neuroprotective and
reparative functions. This is especially the case for chemokines
categorized as “homeostatic”, based on their constitutive expres-
sion in thymic and lymphoid tissues (CCL14, CCL19, CCL20,
CCL21, CCL25, CCL27, CXCL12 and CXCL13), where they reg-
ulate the migration of leukocytes during immune surveillance
(Bachmann et al., 2006; Ito et al., 2011). Of these chemokines,
CCL19, CCL20, CCL21, CCL27 and CXCL12 are expressed
within uninflamed CNS tissues (van der Meer et al., 2000;
Stumm et al., 2002), particularly at CNS endothelial barriers
(Kivisäkk et al., 2004; Reboldi et al., 2009). Two additional
chemokines, CX3CL1 and CXCL14, are also expressed at high
levels in the normal CNS, primarily by neurons (Harrison et al.,
1998; Huising et al., 2004; Banisadr et al., 2011). Ligands as
well as receptors for several CNS homeostatic chemokines are
expressed by neural stem cells (Huising et al., 2004; Kokovay
et al., 2010), while others can be found on microglia and
neurons (Sheridan and Murphy, 2013). These chemokines and
their receptors are therefore involved in a range of homeostatic
processes including immune surveillance, neuro/gliogenesis and
modulation of synaptic transmission. This review will discuss
how homeostatic chemokines protect and maintain normal CNS
functions.
CHEMOKINES REGULATE CNS IMMUNE PRIVILEGE AND
SURVEILLANCE
CNS BARRIERS
Homeostasis of the CNS is maintained within strict limits by
anatomical and immunological barriers that restrict access of
pathogens, solutes, and to an extent, immune cells, to the brain
parenchyma. This review focuses on two of these barriers in
particular; the blood–cerebrospinal fluid (CSF) barrier and blood
brain barrier (BBB), which prevent the exchange of cells and
solutes between the blood and CSF or brain parenchyma, respec-
tively. The BBB is comprised of specialized endothelial cells of
the cerebral microvasculature, surrounding pericytes, and astro-
cytic endfeet, while the blood–CSF barrier is largely made up
of the fenestrated endothelium of the choroid plexus. In addi-
tion to these anatomical barriers, the expression of chemokines
and chemokine receptors at the BBB and blood-CSF barrier
serves as an immunological checkpoint and prevents (during
non-inflammatory/homeostatic conditions) or promotes (during
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neuroinflammation) the infiltration of circulating leukocytes into
the deeper CNS parenchyma and ventricular or subarachnoid CSF
spaces (Figure 1).
FIGURE 1 | Chemokines regulate immune and progenitor cell
homeostasis at multiple CNS barriers. Chemokines expressed by the
CNS vasculature have a role in regulating immune cell and neural progenitor
cell occupancy within perivascular spaces. Expression of CCL19, CCL20,
and CCL21 on meningeal vessels maintain dendritic cell populations
important for immunosurveillance within the boarders of the glia limitans,
limiting antigen presentation cell access to the CNS parenchyma. The
vasculature of the choroid plexus expresses a variety of adhesion molecules
and chemokines, including CCL19 and CCL20 that influence immune cell
adhesion, rolling, and extravasation across the endothelium and pia mater.
CCR6+ and CCR7+ leukocytes enter CSF-containing ventricles and circulate
through the CNS, surveying for antigen and other cues indicative of
inflammation. Subventricular zone (SVZ) neural precursors receive external
cues, namely CXCL12, from the vasculature, that prompts proliferation,
differentiation, and migration. Ependymal cells form a thin epithelial-like
lining of the ventricular system and enclose the niche in which SVZ
progenitors thrive.
As in peripheral lymphoid tissues, expression of chemokines
and their cognate receptors within the CNS are highly region-
alized and regulated in a tissue-dependent manner (Réaux-Le
Goazigo et al., 2013). In particular, endothelial cell chemokines
expressed at the BBB can translocate from the abluminal to
luminal surfaces of post-capillary venules, thereby exerting effects
on circulating leukocytes. Thus, a critical aspect of chemokine
function at the BBB, as in peripheral tissues, is their local-
ization along endothelial cell surfaces and binding to extra-
cellular matrix proteins and glycosaminoglycans (GAGs). The
discovery of chemokines’ ability to direct leukocyte migration
was largely informed through in vitro studies of the movement
of leukocytes towards increasing concentrations of solubilized
chemokines (Zachariae, 1993). These analyses perhaps inappro-
priately fostered the notion that within tissues, leukocytes simi-
larly respond to soluble chemokine gradients; however it is now
recognized that the extracellular matrix and GAGs localize and
concentrate chemokines, preventing their rapid diffusion and
loss of chemotactic effects (Hamel et al., 2009). In particular,
chemokines have been shown to bind with high affinity to hep-
aran sulfate chains of heparan sulfate proteoglycans, immobi-
lizing chemokines and leading to the formation of chemokine
gradients on endothelial surfaces (Johnson et al., 2005; Parish,
2006).
The concept of immune privilege was originally conceived as
a result of experiments that found antigenic material, including
foreign tumors and tissue grafts, failed to elicit a systemic, T
cell-mediated immune response when implanted into the CNS
parenchyma (reviewed in Galea et al., 2007). While the term
immune privilege implies an absence of immunological response
within the CNS, it is now recognized that CNS immune privilege
is not absolute but rather very elaborately controlled. Several
cellular and molecular components that comprise the CNS bar-
riers are responsible for limiting the immune response under
homeostatic conditions.
Microglia and perivascular macrophages are critical com-
ponents of CNS immune surveillance and protection. While
microglia share morphology and many functions with perivas-
cular macrophages, their ontogeny differs. Microglia are myeloid
phagocytes (Nimmerjahn et al., 2005) derived from the yolk
sac during early development (Ginhoux et al., 2010; Kierdorf
et al., 2013) and are found throughout the CNS of adults. Once
activated, microglia initiate a classical innate immune response,
similar to that elicited by peripheral macrophages, and facil-
itate activation of adaptive immunity, secreting inflammatory
cytokines and presenting antigen(s) to reactive lymphocytes. In
adults, perivascular macrophages originate from stem cell niches
in the bone marrow and localize to perivascular spaces, confined
by the BBB around blood vessels, via the circulation (Neumann
and Wekerle, 2013). Perivascular macrophages function similar
to peripheral macrophages, and thus they are crucial for antigen
presentation to and reactivation of lymphocytes, making them a
critical component of CNS-defense against invading pathogens.
Further, elimination of these perivascular cells enhances responses
to inflammatory stimuli, including LPS, suggesting that perivas-
cular macrophages may have a role in controlling initial host-
pathogen responses within the CNS (Serrats et al., 2010). While
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a repertoire of chemokine and chemokine receptors are expressed
by microglia and perivascular macrophages, their function with
regard to antigen presentation is not well understood. However,
it is likely that chemokines underlie the localization of these cells
within their respective CNS compartments. Together, microglia
and perivascular macrophages form another layer of CNS protec-
tion, comprising a cellular barrier to facilitate protection against
invading pathogens as well as immune-mediated bystander CNS
injury.
THE CHOROID PLEXUS AND MENINGEAL BARRIERS
The choroid plexus and the meninges represent pivotal modified
cellular barriers between the blood and CSF or parenchymal
compartments, respectively. The choroid plexus is largely con-
sidered a circumventricular organ, localized in the ventricles,
and constitutes one of the interfaces between the blood and the
CSF (Strazielle and Ghersi-Egea, 2000; Schulz and Engelhardt,
2005). The epithelial cells of the choroid plexus secrete CSF and
thus largely contribute to brain homeostasis, adjusting intracra-
nial volume, buffering extracellular solutes, and supplying cells
of the CNS with micronutrients (Strazielle and Ghersi-Egea,
2000). The vascular endothelial cells of the choroid plexus are
unique from those of the BBB as they lack tight junctions,
more readily enabling diapedesis of cells. Further, as opposed
to postcapillary venules within the parenchyma, which require
cells to traffic across two basement membranes, meningeal cap-
illaries have only a one-layer structure (Wilson et al., 2010). In
addition to representing points of access for circulating immune
cells, the choroid plexus and the meninges also host a local
population of antigen presenting cells. In rats and humans,
choroid plexus- and meninges-associated dendritic cells (DCs)
have been identified, which express major histocompatibility
class II (MHC II) and present antigen to circulating lympho-
cytes (McMenamin, 1999). These DCs are known to sample the
environment by extending processes between adjacent choroid
plexus epithelial cells (Serot et al., 2000), making the choroid
plexus and the meninges major sites of immunosurveillance
(Figure 1).
The localization of DCs in close proximity to the vessels of
the choroid plexus and meninges suggests that these cells express
a set of chemokines that limit their mobility out of these com-
partments. Further, DC turnover dictates that these cells exhibit
temporal expression of chemokine localizing cues to facilitate
their egress from the circulation and into the choroid plexus
and meningeal compartments (Chinnery et al., 2010). DCs are
known to express several chemokine receptors including CXCR3,
CCR6, CCR7, and CXCR4 as well as some others, depending on
their stage of maturation (Charles et al., 2010), and numerous
chemokines have been identified in recruiting DCs into the brain
parenchyma during neuroinflammation as well as prion disease,
viral encephalitis, brain ischemia, parasitic and bacterial CNS
infections (Clarkson et al., 2012). However, it remains unclear
which chemokines are involved in maintaining DCs within CNS
compartments during immune surveillance. Under homeostatic
conditions, the presence of DCs in the stroma of the chroroid
plexus as well as meningeal blood vessels suggest a role for
chemokines that are constitutively expressed at these locations,
such as CCL19, CCL20 and CCL21 (Figure 2). Recent studies
have also demonstrated vessel-associated, DC-like cells in the
CNS perivascular space that extend cell processes into the base-
ment membrane of the glia limitans in the absence of inflam-
mation. These DC-like cells expressed CD11c, but not MHC II
(Prodinger et al., 2011). The authors of this study speculate that
these cells may represent a subpopulation of microglia, cells of
the monocytic lineage, or immature or quiescent DCs capable
of recognizing and presenting antigen. Since these cells extend
processes into the glia limitans, it is possible that they are capable
of sampling and presenting antigen within the perivascular space.
It is possible that abluminally expressed CXCL12, which binds
to CXCR4 expressed by DCs, at the BBB may be important in
retaining these cells within close proximity to the microvascula-
ture, allowing interactions with surveying T cells, but preventing
access to deeper parenchymal tissue.
Given that mature DCs up-regulate expression of cognate
chemokine receptors, including both CCR7 and CXCR4 (Sallusto
et al., 1998), it is possible that expression of these receptors
localize mature DCs to the chroroid plexus (via CCL21) and BBB
(via CCL19 and CXCL12), thus facilitating interactions between
circulating lymphocytes and these antigen presenting cells. Anti-
gen presented by mature DCs and recognized by T cell receptors
(TCRs) results in heterodimerization between TCRs and CXCR4
and is necessary to initiate activation, cytokine secretion, and T
cell migration. Further, CXCL12 has been shown to enhance T cell
responses via costimulation of the TCR (Smith et al., 2013), sug-
gesting that CXCL12 expressed in the perivascular niche may play
an important role in mediating TCR activation during antigen
presentation. Furthermore, heterodimerization of CXCR4 and
TCR (Kremer et al., 2011) triggers TCR signaling via β-arrestin-1
that results in down-regulation of CXCR4 (Schneider et al., 2009;
Fernández-Arenas et al., 2014), perhaps limiting CXCL12 action
at the BBB and preventing prolonged retention of T cells within
the perivascular space (Figures 1 and 2).
The chemokine CXCL12, also known as stromal cell-derived
factor 1 (SDF-1), is expressed as three alternatively spliced iso-
forms (α, β, and γ). Within the CNS, the expression patterns
for CXCL12 is widespread and includes the cortex, olfactory
bulb, hippocampus, cerebellum, meninges, and the endothelium
of the BBB (β and γ isoforms). Further, expression of CXCR4,
the receptor for CXCL12, has been detected in numerous cell
types in the CNS including astrocytes, microglia, oligodendro-
cytes, neurons, and endothelial cells of the BBB (van der Meer
et al., 2000; Stumm et al., 2002). Until recently it was believed
that CXCL12 mediated its effects exclusively via interactions
with CXCR4, however the receptor CXCR7/ACKR3 (Atypical
chemokine receptor 3), formerly the orphan receptor RDC1, has
now been shown to bind CXCL12 as well as CXCL11 (Burns
et al., 2006). While CXCR7/ACKR3 (CXCR7) possesses homology
with conserved domains of G-protein coupled receptors and is
structurally similar to other CXC receptors, ligand binding does
not initiate typical intracellular signaling pathways but instead
results in β-arrestin recruitment and MAP kinase activation
(Rajagopal et al., 2010; Odemis et al., 2012). One function of
CXCR7 appears to be its ability to act as a scavenger receptor for
both CXCL12 and CXCL11, mediating uptake and degradation
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FIGURE 2 | CXCL12 fate determination of perivascular T cells. DC-like
cells have been identified in the perivascular space as well as in the
juxtavascular parenchyma abutting astrocytic end feet and extending
processes into the basement membrane of the glia limitans. These cells
express CD11c but lack MHC II expression suggesting they may be
quiescent DCs capable of recognizing antigen during routine immune
surveillance. It is possible that upon antigen uptake these cells are activated
to up-regulate MHC II expression as well chemokine receptors such as
CXCR4. Interaction with CXCL12 expressed at the abluminal side of the BBB
endothelium could thus function to retain these cells as well as circulating
lymphocytes within the perivascular spaces, facilitating antigen presentation
and recognition. Upon binding to antigen presented in MHC II complexes,
the T cell antigen receptor (TCR) expressed on T cells heterodimerizes with
CXCR4, initiating intracellular signaling cascades that lead to T cell activation
and migration. Recent studies have demonstrated that TCR-activated
β-arrestin signaling down-regulates T cell surface CXCR4 expression,
perhaps removing an important retention cue within the perivascular niche,
thereby promoting entry of T cells into deeper parenchymal tissue. This
process may also be promoted by the release of cytokines due to TCR
binding and T cell activation. Inflammatory cytokines have been shown to
up-regulate levels of CXCL12 as well as the scavenger chemokine receptor
CXCR7. CXCR7 is capable of binding to and internalizing CXCL12, leading to
loss of polarity at the BBB. Relocation of CXCL12 from abluminal to luminal
endothelial surfaces at the BBB has been shown to lead to extensive
leukocyte infiltration and neuroinflammation in experimental autoimmune
encephalomyelitis (EAE) and multiple sclerosis (MS).
of these ligands, and thus regulating extracellular chemokine
concentrations (Boldajipour et al., 2008; Naumann et al., 2010).
The ability of CXCR7 to act as a sink for CXCL12 may have
implications for controlling chemokine gradients and directing
hematopoetic cells, leukocytes and other cell subsets to periph-
eral lymphoid tissues as well as the CNS. CXCR7 expression
within the CNS of rats was detected via in situ hybridization,
with CXCR7 mRNA transcripts identified in the ventricular
ependyma, the choroid plexus, neuronal and astroglial cells as
well as cells of the vasculature (Schönemeier et al., 2008a,b).
Interestingly, studies have identified the endothelium of the BBB
as a source of constitutive expression of CXCL12 and CXCR4
as well as CXCR7, suggesting a role for this chemokine/receptor
axis in regulating immune cell trafficking at the BBB during
homeostasis.
These initial observations of CXCL12/CXCR4 expression by
BBB endothelial cells were expanded by McCandless et al. who
demonstrated the importance of CXCL12 expression and polar-
ization at the BBB in the perivascular localization of infiltrat-
ing mononuclear cells (McCandless et al., 2006). These studies
determined that CXCL12 protein is normally localized along
the abluminal surface of endothelium within the CNS of mice
and humans. During the autoimmune diseases experimental
autoimmune encephalomyelitis (EAE) in mice and multiple
sclerosis (MS) in humans, CXCL12 localization shifts toward
a more luminal expression pattern, which is accompanied by
increased parenchymal entry of CXCR4 positive mononuclear
cells. Loss of CXCL12 polarity and luminal display of this
chemokine was also associated with the detection of activated
CXCR4 on leukocytes within the blood, suggesting that reloca-
tion of CXCL12 in this manner not only promotes the egress
of leukocytes from perivascular spaces but also increases their
capture and translocation across the BBB. These results suggest
that abluminal expression of CXCL12 at the CNS vasculature
during homeostatic conditions is a component of immune priv-
ilege essential for limiting extravasation of circulating leukocytes
across endothelial barriers, while restricting immune cells to the
perivascular space, limiting their access to parenchymal tissues
(Figure 2).
CHEMOKINE SIGNALING AT CNS BARRIERS IN HEALTH AND DISEASE
The CXCL12, CXCR4, CXCR7 axis
More recently, the role of CXCR7 in regulating CXCL12 polar-
ity at the BBB was examined by Cruz-Orengo et al. (2011).
Consistent with earlier reports (Schönemeier et al., 2008a,b),
results from this study found constitutive CXCR7 expression by
the CNS vasculature. In addition, CXCR7 message was detected
in primary cultures of murine brain microvascular endothelial
cells (BMECs). During EAE, CXCR7 levels increased at post-
capillary venules of spinal cord white matter, with concomitant
loss of CXCL12 polarity at the BBB (Figure 2). Administra-
tion of an antagonist to the CXCR7 receptor prevented loss of
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abluminal CXCL12, limiting leukocyte entry at the BBB and
the formation of parenchymal inflammatory lesions. In vitro
experiments using murine BMECs determined that proinflam-
matory T cell cytokines, interleukin (IL)-1β and IL-17, increased
expression of CXCL12 and CXCR7, respectively, with increased
localization of CXCL12 with lysosomal markers. Further, these
cytokines enhanced uptake of exogenous CXCL12, which was
inhibited in a dose-dependent manner by antagonism of CXCR7,
suggesting that under inflammatory conditions, CXCR7 facil-
itates internalization of CXCL12, leading to loss of polarity
at the BBB seen in EAE as well as MS (Cruz-Orengo et al.,
2011).
Taken together, these results suggest a critical role for CXCR7
in mediating CXCL12 abundance and localization during neu-
roinflammation, but importantly may offer clues to the role of
this chemokine/receptor axis during homeostasis. In the absence
of inflammation, CXCL12 expression is localized on the ablu-
minal surface of the BBB, despite constitutive expression of
CXCR7 at the CNS microvasculature. This perhaps indicates
that CXCR7 normally functions to maintain and replenish basal
CXCL12 through internalization and recycling to the cell surface,
as has been demonstrated in cell lines engineered to express
CXCR7 (Luker et al., 2010) and in studies of germ cell migration
(Mahabaleshwar et al., 2012). At this time, it is unclear if CXCR7
plays a similar role in mediating extravasation of immune cells
across the BBB, however the maintenance of CXCL12 polarity
during homeostatic conditions indicates that this mechanism
may be an essential function of CXCR7 in non-pathogenic
states.
CCL2 and CCR2
CCL2 is also known as monocyte chemoattractant protein-1
(MCP-1), an inflammatory chemokine expressed by immune
cells as well as other stromal cell types. In response to inflam-
matory cues or tissue injury, CCL2 is up-regulated to recruit
CCR2+ monocytes, memory T cells, and DCs (Kolattukudy and
Niu, 2012). Within the CNS, CCL2 is expressed by neurons,
astrocytes, and microvascular endothelial cells of the BBB, and
the role of CCL2 in recruiting monocytes and macrophages
into the CNS under inflammatory conditions has been well
characterized (Conductier et al., 2010; Réaux-Le Goazigo et al.,
2013). Nevertheless, recent studies have also demonstrated a role
for CCL2 under homeostatic conditions and suggest that the
expression of both CCL2 and CCR2 is necessary for perivas-
cular and meningeal macrophage recruitment and turnover in
the brains of mice (Schilling et al., 2009). Additionally, Stowe
et al. have shown that hypoxic preconditioning of mice with
8% oxygen for 4 h led to an up-regulation of CCL2 by neu-
rons as well as cerebral endothelial cells that was associated
with increased tolerance to subsequent cerebral ischemia. This
study also found that hypoxic preconditioning and up-regulation
of CCL2 at the cerebral microvasculature was not sufficient to
increase monocyte trafficking across the BBB (Stowe et al., 2012).
These results suggest that CCL2 levels on microvascular endothe-
lial cells can be up-regulated in the absence of inflammation
and may function to confer a neuroprotective phenotype at
the BBB.
LEUKOCYTE HOMING IN CEREBROSPINAL FLUID
The intensity of immune responses in the CNS increases with
proximity to the ventricles of the brain (Matyszak and Perry,
1996), and materials implanted within the subarachnoid space
and meninges are likewise capable of eliciting a robust immune
response. These observations suggest that the ventricular and
subarachnoid CSF may function as sites of physiological immune
surveillance. Consistent with this, cellular infiltrates that accumu-
late within the meningeal membranes during neuroinflammatory
events have been observed to arrange in formations resembling
secondary lymphoid structures (Howell et al., 2011), while infil-
trates within the parenchyma do not exhibit the features of
lymphoid neogenesis.
The CCL19, CCL21, and CCR7 axis
In peripheral lymphoid tissues, the chemokine CCL19 guides
CCR7-expressing B cells, naïve T cells, and DCs into lym-
phoid tissue under physiological conditions (Bachmann et al.,
2006). Along with the chemokine, CCL21, CCL19 is constitu-
tively expressed in lymphoid tissues including the spleen, Peyer’s
patches, and lymph nodes, where they regulate homing of leuko-
cytes (e.g., CCR7+ naïve T cells and mature DCs) and facil-
itate antigen-specific interactions within subcompartments of
secondary lymphoid tissue (e.g., T cell zones and high endothelial
venules). Thus CCL19 and CCL21 serve to generate adaptive
immune responses and are critical for developing and maintain-
ing secondary lymphoid tissues in the periphery and have also
been implicated in lymphoid neogenesis within the CNS.
Kivisäkk et al. have shown that CD4+ T cells are restimu-
lated within the subarachnoid space by encounters with MHC
II+ antigen presenting cells prior to the onset of inflammation
in EAE, providing further support to the concept of the sub-
arachnoid space and meninges as a site of routine immunolog-
ical surveillance (Kivisäkk et al., 2003, 2009). Studies from this
group have also characterized the phenotype of leukocytes in
the CSF of patients without CNS inflammation and found that
these cells predominantly are CD4+/CD45RA−/CD27+/CD69+,
consistent with the profile of activated central memory T cells
that also express high levels of CCR7 and L-selectin. Given that
CCL21, a ligand for CCR7, has been detected at the choroid
plexus epithelium (Kivisäkk et al., 2004), it is possible that this
chemokine directs CCR7+ activated memory T cells to cross the
blood-CSF barrier during homeostatic immune surveillance of
the CNS (Figure 1). The expression of CCR7 by these memory
T cells also suggests that this chemokine receptor is important in
maintaining these lymphocytes within the CNS, perhaps via in
interactions with CCL19 or CCL21 expressed at the brain vascula-
ture during physiologic as well as neuroinflammatory conditions.
Additionally, the expression of CCR7 by memory T cells within
the CSF may facilitate homing back to peripheral lymphoid tissue,
particularly the deep cervical lymph nodes via drainage of the CSF
across the cribriform plate and nasal mucosa (Goldmann et al.,
2006; Laman and Weller, 2013).
CCL19 mRNA transcripts are constitutively expressed on
the endothelial cells of post-capillary venules in the brain and
spinal cord under physiologic conditions, while expression of
CCL21, another CCR7 ligand, is induced at post-capillary venules
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only during neuroinflammation (Alt et al., 2002; Krumbholz
et al., 2007). CCL19 transcripts were also detected in nor-
mal human brain homogenates while expression levels were
elevated in homogenates from active and inactive MS lesions.
Kivisäkk et al. examined the expression of CCR7, CCL19, and
CCL21 in brain autopsy material and CSF samples from MS
patients. In contrast to previous observations in mice, this
study reported a lack of CCL19 or CCL21 protein expression
in endothelial or parenchymal cells of non-lesioned white mat-
ter or in active or chronic MS lesions, but did find strong
CCL21 immunoreactivity within the choroid plexus epithe-
lium (Kivisäkk et al., 2004). The expression of these lymphoid
chemokines in the CNS implies that CCL19, and to a lesser
extent CCL21, may signal circulating leukocytes that normally
home to peripheral lymphoid tissues. Based on the constitutive
expression of CCL19 within the CNS, it is possible that this
lymphoid chemokine may also function in physiological immune
surveillance of the CNS, perhaps at the level of the postcap-
illary venules of the BBB by recruiting and retaining T cells,
as well as other cells known to express CCR7 (e.g., B cells;
Figure 1).
CCL20 and CCR6
The receptor CCR6 is unique among chemokine receptors in
that it binds a single chemokine ligand, CCL20. In the periph-
ery, CCR6 regulates mucosal immunity via several mechanisms,
including mediating the recruitment of DCs to epithelial barriers
during inflammation and homing of helper T cells and DCs to the
mucosal lymphoid tissue of the gut (Ito et al., 2011). Accordingly,
CCL20 is constitutively expressed at epithelial barriers of the skin,
lungs, gut and choroid plexus, typically at low levels under non-
pathologic conditions. However, in response to proinflamma-
tory cytokines, CCL20 levels can be substantially up-regulated.
In addition to recruiting leukocytes to mucosal barriers, recent
experiments have implicated CCL20/CCR6 in the trafficking of
T cells to the CNS across the choroid plexus during immune
surveillance as well as neuroinflammation (Figure 1). Reboldi
et al. demonstrated that CCL20 was constitutively expressed by
the choroid plexus epithelium in both mice and humans, but was
not expressed by endothelial cells of the parenchymal microves-
sels. Mice lacking CCR6, which is expressed on IL-17-producing
T cells (Th17 cells), were highly resistant to active induction of
EAE by MOG immunization. Further, in these CCR6-deficient
mice, CD45+ cells accumulated within the parenchyma of the
choroid plexus, but failed to enter the CNS. Passive transfer
of EAE into CCR6 knockout mice using MOG-specific WT T
cells was able to rescue disease susceptibility and led to recruit-
ment of T cells, including those lacking CCR6, into the CNS
parenchyma. This finding suggests that the initial trigger for
inflammation in this EAE model was due to a CCR6-dependent
entry of Th17 cells into the uninflamed CNS via trafficking
across the CCL20-expressing choroid plexus epithelium, lead-
ing to a second wave of infiltration of lymphocytes that does
not rely on CCR6 (Reboldi et al., 2009). The results from this
study led these authors to speculate that CCL20/CCR6 is crit-
ical for surveillance of the CNS via the CSF and subarachnoid
spaces.
CCL20 and CCR6 may also play a role in the entry of
autoreactive T cells during EAE at the dorsal blood vessels of
the fifth lumbar vertebrae (L5) of the spinal cord via an IL-
6-mediated mechanism. Arima et al. have demonstrated that
CCL20 is normally expressed by vasculature at this site. IL-6
mediated upregulation of CCL20 was induced by stimulating
the soleus muscle, which led to the infiltration of autoreactive
T cells across the BBB in an adoptive transfer model of EAE.
These experiments provided evidence that sensory stimulation
can trigger chemokine-mediated accumulation of T cells within
the CNS microvasculature at specific locations within the lumbar
spinal cord. These observations led the authors to postulate that
expression of CCL20 at the dorsal L5 blood vessels, even in the
absence of pathogenic T cells, could represent a “gateway” by
which leukocytes expressing CCR6 could cross the BBB and gain
entry into the CNS parenchyma (Arima et al., 2012).
CHEMOKINES AND MAINTENANCE OF THE ADULT CNS
PROGENITOR AND ENDOTHELIAL CELL FUNCTION
At one time, loss of neurons was thought to be irreversible in
the adult brain; we now know that generation of replacement
cells is an ongoing process in rodents and humans (Kuhn et al.,
1996; Eriksson et al., 1998). Adult neurogenesis occurs in localized
“neurogenic niches” from precursors that reside adjacent to the
lateral ventricles, in the subventricular zone (SVZ) and in the sub-
granular zone (SGZ) of the hippocampus (Gage, 2000; Doetsch
and Scharff, 2001; Alvarez-Buylla and Lim, 2004; Zhao et al.,
2008; Sanai et al., 2011). Stem cells require extracellular signals
produced by the CNS milieu to regulate their ability to self-renew,
proliferate, and differentiate (Sanai et al., 2011). Cues within these
local microenvironments perpetuate new neurons and facilitate
their integration into the existing brain circuitry (van Praag et al.,
2002; Zhao et al., 2008). Neural progenitor cells (NPCs) give rise
to adult neurons, astrocytes, and oligodendrocytes, and can be
classified into several lineages. GFAP+ astrocyte-like type B cells
line the lateral ventricle and extend processes into the SVZ plexus
blood vessels (Mirzadeh et al., 2008; Shen et al., 2008; Tavazoie
et al., 2008). During lineage progression, type B cells give rise to
transit amplifying type C cells (Pastrana et al., 2009). Type C cells
rapidly divide and give rise to type A neuroblasts, which prolifer-
ate as they migrate in chains along blood vessels (Shen et al., 2008;
Tavazoie et al., 2008). The endothelial cells that make up the BBB
vasculature serve as neurogenic “highways”, mediating progenitor
cell trafficking and differentiation by providing external signage
as guidance cues.
The CNS endothelium is essential for maintenance and home-
ostasis of the neural progenitor pool. In the adult, bone marrow-
derived endothelial progenitor cells (EPCs) express CXCR4 and
respond to CXCL12 as well as other cytokines to augment neo-
vascularization for restoration of homeostasis following CNS
injury (Zhang et al., 2002; Zheng et al., 2007; Yamaguchi et al.,
2003). These epithelial cells directly or indirectly give rise to all
the neurons, astrocytes, and oligodendrocytes in the adult brain
(Deverman and Patterson, 2009). Not only does the endothelium
give rise to CNS progenitors, the neurogenic niche is localized
around the vasculature. Approximately 47% of dividing progeni-
tor (type B cells) and 46% of transit amplifying (type C) cells are
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located within 5 microns of the endothelium (Shen et al., 2004,
2008). These progenitors directly contact the vessels of the SVZ
in areas devoid of astrocyte end-feet and pericyte coverage, sug-
gesting the vasculature endothelium, in particular, is an essential
matrix and source of external cues for NPCs (Shen et al., 2008;
Teng et al., 2008).
THE CXCL12/CXCR4/CXCR7 AXIS AND NEURAL PROGENITOR CELLS
Chemokines expressed by the vasculature in the adult CNS are
dynamically or constitutively regulated to provide migratory, pro-
liferative, or differentiation cues to neurons and glia (Deverman
and Patterson, 2009). Similar to hematopoietic progenitor cells
in the bone marrow, in which CXCR4-CXCL12 signaling main-
tains the progenitor pool (Sugiyama et al., 2006), proliferative
SVZ progenitor cells home to endothelial cells in the CNS in
a CXCL12- and CXCR4-dependant manner under physiologic
conditions. Kokovay et al. demonstrated that in early progenitor
and transit amplifying cells, epidermal growth factor receptor
and α6 integrin is up-regulated downstream of CXCL12 binding,
enhancing the ability of activated NPCs to bind laminin on the
CNS vasculature (Figure 3). Further, they showed that CXCL12
FIGURE 3 | The neurovascular unit promotes NPC survival. Within the
neurovascular unit, multiple cell types promote the survival and
maintenance of NPCs via expression of the CXCL12/CXCR4/CXCR7
chemokine axis. NPCs express both CXCR4 and CXCR7, capable of
heterodimerization. Binding of this receptor complex to CXCL12 leads to
NPC survival via phosphorylation of ERK1/2. The binding of CXCL12 to
CXCR4 on NPCs promotes adhesion molecule expression for enhanced
attachment of NPCs to endothelial cells, a rich source of growth factors
important for NPC survival and proliferation. CXCR4 activation on NPCs is
also critical to sustain the pool of neural-committed progenitor cells within
neurogenic niches. Pericytes are thought to express CXCR4; however the
downstream effects of CXCR4 signaling in pericytes are largely unknown.
CXCR7 expression is known to contribute to the migratory capacity of
NPCs, particularly in the context of entering the rostral migratory stream
and traveling to the olfactory bulb. Axons have also been shown to express
CXCR7 during development as well as during neuroinflammation, although
its function is largely not understood.
regulates the migration of neuroblasts from the SVZ (Kokovay
et al., 2010), suggesting that endothelial CXCL12 can regulate
progenitor cell occupancy of and departure from the vasculature
niche of the adult SVZ. Similarly, in the SGZ, Schultheiss et al.
have recently demonstrated that neuronal-committed progeni-
tor cells express CXCR4 and that CXCR4 is phosphorylated in
a CXCL12-dependent fashion (Figure 3). Further, deletion of
CXCR4 in NPCs of adult mice resulted in reduced neurogenesis,
specifically, a reduction in Sox2+ early progenitors, NeuroD+
neuronal-committed progenitors, and doublecortin+ immature
neurons was observed (Schultheiß et al., 2013). Together, these
studies suggest that CXCL12-mediated CXCR4 activation is
required for maintenance of NPCs in neurogenic zones of the
adult CNS.
Multiple pathways are known to regulate CXCR4 activation in
neurogenesis. During development, chemokines position neural
progenitors in the SGZ such that they are exposed to a range
of neurogenic factors, including Wnt and Sonic hedgehog (Shh;
Klein et al., 2001; Machold et al., 2003). These factors are criti-
cal for the maintenance of adult neurogenesis as Shh promotes
proliferation of NPCs (Machold et al., 2003) and manipulation
of the Wnt pathway nearly abolishes neurogenesis in the adult
hippocampus (Lie et al., 2005). It is now known that CXCR4 is a
downstream target of Wnt signaling, suggesting that Wnt induces
CXCL12-mediated processes in NPCs via receptor regulation
(Choe and Pleasure, 2012).
The alternate receptor for CXCL12, CXCR7, has also been
shown to have a prominent role in adult neurogenesis. Zhu
et al. demonstrated that both CXCR4 and CXCR7 are required
for the survival of human NPCs. While CXCR4 is broadly
expressed on the surface of human NPCs, CXCR7 was primarily
localized in early endosomes, quickly trafficking to the plasma
membrane to mediate CXCL12 endocytosis. Treatment of human
NPCs with exogenous CXCL12, however, led to CXCR4/CXCR7
colocalization and downstream ERK1/2 signaling, which was
shown to be essential for NPC survival (Zhu et al., 2012). In
another study, CXCR7 expression regulated the migratory behav-
ior of early neurons in the forebrain. CXCR7, but not CXCR4,
was expressed by olfactory interneuron precursors, and down-
regulation of CXCR7 impacted the ability of the precursors
to integrate into the rostral migratory stream, the pathway to
the olfactory bulbs (Tiveron et al., 2010). These studies sug-
gest that CXCR7 has a prominent role in adult neurogenesis
both in the context of and independent of CXCR4 signaling
(Figure 3).
The CXCL12/CXCR4/CXCR7 axis has multiple roles in the
homeostasis of adult neurogenesis. However, it is becoming
increasingly clear that this axis may be up-regulated following
injury including stroke (Hill et al., 2004; Wang et al., 2012),
traumatic brain injury (Israelsson et al., 2008), or demyelination
(Carbajal et al., 2010, 2011; Patel et al., 2010, 2012; Williams
et al., 2014) to generate replacement cells and restore normal CNS
function.
CXCL12 AND CXCL14 REGULATE HIPPOCAMPAL NEUROGENESIS
Following homology cloning, phylogenetic analysis revealed that
CXCL14 is one of the oldest chemokines (Huising et al., 2004), yet
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its functions are relatively unknown. Considered a homeostatic
chemokine, CXCL14 (BRAK; breast and kidney derived) is con-
stitutively expressed in many regions of the brain (Huising et al.,
2004) including the cortex, basal ganglia, septum, hippocampus,
and hypothalamus (Banisadr et al., 2011; Yamamoto et al., 2011).
It is thought to have an opposing role to CXCL12 (Banisadr
et al., 2011; Tanegashima et al., 2013) due to its ability to bind
a shared receptor, CXCR4 (Tanegashima et al., 2013). CXCL14 is
highly expressed in many regions of the adult brain, including the
hippocampus, and may regulate synaptic inputs to adult NPCs
(Banisadr et al., 2011). The early development of NPCs within
the SGZ is regulated by excitatory GABAergic synaptic inputs
that promote synaptic maturity (Ge et al., 2007; Ma et al., 2009).
These newborn neurons mature and are synaptically integrated
into the dentate gyrus of the hippocampus (van Praag et al., 2002).
GABAergic synapses on adult NPCs are sensitive to CXCL12
and CXCL14, which enhance (Bhattacharyya et al., 2008) and
inhibit the effects of GABA (Banisadr et al., 2011), respectively.
These findings suggest that CXCL12 and CXCL14 work to regulate
hippocampal integrity in mature mammals. This is consistent
with experiments using a CXCR4 antagonist in adult mice where
blockade of CXCR4 signaling impaired recognition and memory
(Parachikova and Cotman, 2007). Taken together, these studies
suggest that CXCL12 and CXCL14 have an opposing role, regu-
lating NPC responses to synaptic stimulation, and maintaining
balance in homeostatic NPC turnover in the adult brain.
CX3CL1 MAINTAINS THE NEUROGENIC NICHE
CX3CL1 (fractalkine) is much longer than most chemokines (373
vs. ∼80 AAs) and also exists in two forms: a 95 kDa membrane-
bound form with an N-terminal chemokine domain, a glyco-
sylated mucin-like stalk, a hydrophobic transmembrane region
and an intracellular C-terminal domain; and a 70 kDa soluble
form that contains only the N-terminal chemokine domain.
The soluble chemokine domain of CX3CL1, when cleaved, can
act as a signaling molecule (Chapman et al., 2000), inducing
chemotaxis in T cells and monocytes (Hermand et al., 2008),
whereas its membrane-tethered mucin stalk can serve as a cell
adhesion molecule, via binding of the CX3CL1 receptor, CX3CR1
(Haskell et al., 1999). Under physiologic conditions, CX3CL1 is
highly expressed by a variety of neurons throughout the CNS
(Hatori et al., 2002), with especially high levels in hippocampal
neurons (Sheridan and Murphy, 2013). Neurons and microglia
both express its receptor, CX3CR1 (Hatori et al., 2002), which
regulates memory formation and synaptic plasticity via direct
effects on glutamatergic synapses (Hoshiko et al., 2012; for an
extensive review, see Sheridan and Murphy, 2013).
CX3CL1 has been shown to play a key role in maintaining
adult neurogenesis via indirect mechanisms that modify the CNS
microenvironment. CX3CL1 normally limits microglial activation
and expression of proinflammatory cytokines including IL-1β, IL-
6, and tumor necrosis factor (TNF)-α (Bachstetter et al., 2011;
Rogers et al., 2011), which act directly on NPCs (Monje et al.,
2003; Iosif et al., 2006; Koo and Duman, 2008). Thus, both genetic
and antibody-based blockade of CX3CR1 signaling attenuates
the inhibition of microglial activation and impacts hippocampal
neurogenesis in adult animals. With age, there is an increase in
activated microglia, which can promote an inflammatory milieu
(Gemma et al., 2007) and contribute to age-related declines in
neurogenesis (Rao et al., 2006; Ben Abdallah et al., 2010). Both
exogenous CX3CL1 or IL-1R antagonist reverse this decline in
aged animals. In addition, cleaved CX3CL1 acts as a sensor for
neuronal stress, which stimulates microglia to phagocytose excito-
toxic neurons (Noda et al., 2011). Given the many facets in which
CX3CL1/CX3CR1 signaling works to inhibit inflammation and
maintain a milieu skewed towards quiescence, it is probable that
CX3CL1 contributes to the preservation of an optimal neurogenic
niche for the development, proliferation, and integration of NPCs
within the adult CNS.
Taken together, CX3CL1 plays an important role in mainte-
nance of homeostasis in the adult CNS by mediating neuron-
microglia interactions during physiologic conditions. Following
CX3CR1 activation, microglia are known to remove excess neu-
rons and support maturing synapses (Hoshiko et al., 2012;
Cunningham et al., 2013; Lenz et al., 2013; Ueno et al., 2013),
eliminate apoptotic neural progenitors during adult hippocampal
neurogenesis (Sierra et al., 2014), and remodel neuronal circuitry
during learning and memory processes (Schafer et al., 2012;
Parkhurst et al., 2013). Unmanipulated adult mice deficient in
CX3CR1 had a reduction in “synaptic multiplicity”, in which fewer
boutons synapsed with more than one postsynaptic spine on a
single dendrite. This resulted in reduced connectivity strength
between regions of the hippocampus (Zhan et al., 2014), sug-
gesting that CX3CL1 is required for adult hippocampal plasticity.
It is clear that CX3CL1 is crucial in maintaining homeostasis in
the adult CNS; however mechanisms downstream of membrane-
bound CX3CL1- CX3CR1 binding, as pertains to normal physiol-
ogy, remain to be fully elucidated.
CONCLUDING REMARKS
While chemokines have historically been thought of as mediators
of cell migration, recent evidence suggests that chemokines have
the capacity to regulate a number of cellular functions critical to
inflammatory processes as well as maintenance of homeostasis.
Though the characterization of homeostatic chemokines stems
from their roles in lymphoid tissues, many parallels can be drawn
in the CNS, particularly in the context of the vasculature. Several
chemokines contribute to immune cell trafficking and activa-
tion during immunosurveillance (CCL2, CCL19, CCL20, CCL21,
CXCL12); regulation of neural progenitor cell migration, pro-
liferation, differentiation, and integration (CXCL12, CXCL14);
and maintenance of quiescence (CX3CL1), orchestrating the bal-
ance of homeostasis, while providing immune protection, under
physiologic conditions in the CNS. While many functions of
chemokines during homeostasis have been identified, there is still
much to learn.
Chemokines are known to participate in the function of
pericytes within the CNS during physiologic conditions, par-
ticularly at the level of the vasculature; however, the role of
many of these chemokines is still largely unknown. Pericytes are
a key component to the neurovascular unit within the CNS,
contributing to endothelial cell tight junction stability and BBB
formation (Balabanov and Dore-Duffy, 1998). Song et al. demon-
strated that CXCL12 increases pericyte motility in vitro and in
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a tumor xenograft model in vivo (Song et al., 2009), suggesting
that pericytes express CXCR4 that facilitates their recruitment
to endothelial cells (Virgintino et al., 2013). Vascular pericytes
have also been shown to respond to ligands of CXCR3, inducing
chemotactic as well as mitogenic effects, stimulating proliferation
(Bonacchi et al., 2001). Further, pericytes are known to be a
source of chemokine ligands, including CCL3 and CCL4, both
constitutively and in response to LPS (Kovac et al., 2011). Due
to the spatial distribution of pericytes within the neurovascular
unit (Figure 3), they are likely to have an important role with
regard to maintenance of homeostasis via chemokine regulation.
Elucidating the role of chemokines in pericyte function will aid in
the understanding of these cells in the context of homeostasis and
disease in the CNS.
CCL27 (cutaneous T cell-attracting chemokine, CTACK) is
largely expressed by keratinocytes, binds to the receptor CCR10,
and may serve as an important regulator of homeostatic immune
surveillance. CCL27 has been implicated in inflammatory aller-
gic reactions, primarily in homing memory T cells to the skin
(Morales et al., 1999; Huang et al., 2008). Interestingly, Gunsolly
et al. have characterized the expression of CCL27 in the cerebral
cortex and limbic regions of the CNS in mice. During allergic
inflammation induced by intranasal injection of ovalbumin, a
variant of CCL27 was up-regulated in the olfactory bulb and was
accompanied by infiltration of T cells (Gunsolly et al., 2010),
suggesting that CCL27 also has a role in T cell recruitment in the
CNS. This pathway may represent a point of access to the CNS
tissue for leukocytes that bypasses the BBB, which is lacking at
the nasal mucosa, cribriform plate, and perineural spaces of the
olfactory bulb (Danielyan et al., 2009). Continued investigation of
chemokines in the adult CNS will provide new insights into their
functions during physiologic conditions and maintenance of CNS
protection, and may identify targets for restoring homeostasis
following CNS injury.
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